us going digital currency snippets

The Bank of Japan believes that the cost of waiting for the next rate hike is not high, but it is also open to raising interest rates this month. According to informed sources, Bank of Japan officials believe that there is almost no cost to wait before raising interest rates, and they are still open to raising interest rates next week, depending on data and market development. According to people familiar with the matter, even if the Bank of Japan decides to wait until January next year or a little longer before raising interest rates, the relevant authorities believe that this will not bring huge costs, because there are signs that there is little risk of inflation overshoot. According to people familiar with the matter, officials think it is only a matter of time before the next rate hike, because the economy and inflation are in line with their forecasts. According to people familiar with the matter, officials will make a final decision only after carefully evaluating the data and financial markets before announcing the policy decision in December. Bank of Japan Governor Kazuo Ueda and his committee will discuss next week whether it is necessary to raise the benchmark interest rate from 0.25%. Unlike the situation in July, the yen did not show a strong weakness, so the Bank of Japan believes that the risk of the yen pushing up inflation has weakened.Brent crude oil exceeded $73/barrel, up 1.57% in the day.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)

Putin had a phone conversation with Hungarian President Orban on the situation in Ukraine.The China Securities Association held a meeting of directors and all members of the regional equity market professional committee, and the meeting of directors and all members of the regional equity market professional committee of the Securities Association was held in Chongqing on December 5th. The regional equity market should further thoroughly implement the spirit of the Third Plenary Session of the 20th CPC Central Committee, take the new "National Nine Articles" as a guide, persist in comprehensively deepening reforms, strive to break down institutional and institutional obstacles and structural problems, explore innovative pilot projects according to local conditions, develop new quality productivity, and establish a basic service system, a comprehensive financial service system and a listing standard cultivation system that are in line with local conditions and the characteristics of small and medium-sized enterprises, so as to continuously improve the comprehensive financial service capability. At the same time, the positioning function of regional equity market is still in the exploration stage, and innovation exploration in various places should pay attention to both standardization and development, and various risk prevention and control and supporting measures should be in place simultaneously.Health Yuan: Obtained the commitment letter of stock repurchase loan from financial institutions of no more than 238 million yuan. Health Yuan announcement, the company recently obtained the commitment letter of loan from Industrial Bank, with a loan amount of no more than 238 million yuan, no more than 90% of the upper limit of repurchase amount, and a loan period of no more than 36 months, which is specially used to repurchase shares of listed companies. The total amount of the company's actual loan and the amount of the repurchased funds shall not exceed the upper limit of the amount of this repurchase program. The commitment letter of the financial institution's stock repurchase loan obtained this time does not represent the company's commitment to the repurchase amount. The specific number of shares repurchased shall be subject to the actual number of shares repurchased at the expiration of the repurchase period.

Shanghai Ultra-high-definition Audio-visual Industry Cluster is unveiled, aiming to reach 200 billion yuan by the end of the Tenth Five-Year Plan. Jing 'an will implement 21 major tasks of the "Four Key Projects" of the Ultra-high-definition Audio-visual Industry, and strive to reach 200 billion yuan by the end of the Tenth Five-Year Plan, with the output of ultra-high-definition audio-visual content exceeding 10,000 hours, making it a highland for the production of ultra-high-definition audio-visual content in China and an ultra-high-definition audio-visual industry cluster with global influence.Today, a total of 95 A-shares traded in bulk, with Beijing-Shanghai High-speed Railway, Salt Lake Shares and Jin Chengxin among the top. Today (December 11th), a total of 95 A-shares traded in bulk, with a total turnover of 6.031 billion yuan, among which Beijing-Shanghai High-speed Railway, Salt Lake Shares and Jin Chengxin ranked first, with turnover of 3.797 billion yuan, 478 million yuan and 259 million yuan respectively. In terms of transaction price, 14 stocks were traded at parity, 4 at premium and 77 at discount; Yingtai Bio, Songyuan Resources and Beijing-Shanghai High-speed Railway are among the top premium rates, with premium rates of 9.13%, 2.19% and 1.61% respectively. Gobijia, Junpu Intelligent and Guoke are among the top discount rates, with discount rates of 28.86%, 25.79% and 22.46% respectively.Good shop: shareholder Dayong Co., Ltd. reduced its holdings by 3% in this reduction plan, which has reached the upper limit of the reduction plan. The good shop announced that during the period from December 2, 2024 to December 10, 2024, shareholder Dayong Co., Ltd. reduced its holdings by 4,560,400 shares, accounting for 1.14% of the company's total share capital. As of December 11, 2024, shareholder Dayong Co., Ltd. has reduced its shareholding by 3% in this reduction plan, which has reached the upper limit of the reduction plan, and the implementation of this reduction plan has been completed.